Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.559ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.406ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
ER.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.640ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.6 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.27ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.9 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XUENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.3 (Omicron)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.16.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.372ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.425ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.132 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KB.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XANENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EU.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used